Pathophysiology

Dengue

Volumn , Issue , 2008, Pages 285-326

  Halstead, Scott B ^a  

^a Pediatric Dengue Vaccine Initiative   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85116536485     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1142/9781848162297_0009     Document Type: Chapter

References (171)

1. Durbin AP, Karron RA, Sun W, Vaughn DW, Reynolds MJ, Perreault JR et al. Attenuation and immunogenicity in humans of a live dengue virus type-4 vaccine candidate with a 30 nucleotide deletion in its 3′-untranslated region. Am J Trop Med Hyg 2001; 65: 405-413.
2. Sangkawibha N, Rojanasuphot S, Ahandrik S, Viriyapongse S, Jatanasen S, Salitul V et al. Risk factors in dengue shock syndrome: a prospective epidemiologic study in Rayong, Thailand. I. The 1980 outbreak. Am J Epidemiol 1984; 120: 653-669.
3. Burke DS, Nisalak A, Johnson DE, Scott RM. A prospective study of dengue infections in Bangkok. Am J Trop Med Hyg 1988; 38(1): 172-180.
4. Thein S, Aung MM, Shwe TN, Aye M, Zaw A, Aye K et al. Risk factors in dengue shock syndrome. Am J Trop Med Hyg 1997; 56(5): 566-572.
5. Graham RR, Juffrie M, Tan R, Hayes CG, Laksono I, Ma’roef C et al. A prospective seroepidemiologic study on dengue in children four to nine years of age in Yogyakarta, Indonesia. Studies in 1995-1996. Am J Trop Med Hyg 1999; 61(3): 412-419.
6. Halstead SB, Lan NT, Myint TT, Shwe TN, Nisalak A, Soegijanto S et al. Infant dengue hemorrhagic fever: research opportunities ignored. Emerg Infect Dis 2002; 12: 1474-1479.
7. Hung NT, Lei HY, Lan NT, Lin YS, Huang KJ, Lien LB et al. Dengue hemorrhagic fever in infants: a study of clinical and cytokine profiles. J Infect Dis 2004; 189: 221-232.
8. Kliks SC, Nimmannitya S, Nisalak A, Burke DS. Evidence that maternal dengue antibodies are important in the development of dengue hemorrhagic fever in infants. Am J Trop Med Hyg 1988; 38(2): 411-419.
9. Halstead SB. Immunological parameters of togavirus disease syndromes. In: Schlesinger RW (ed.) The Togaviruses: Biology, Structure, Replication. Academic, New York, 1980, pp. 107-173.
10. Marchette NJ, Halstead SB, Falkler WA Jr, Stenhouse A, Nash D. Studies on the pathogenesis of dengue infection in monkeys. III. Sequential distribution of virus in primary and heterologous infections. J Infect Dis 1973; 128(1): 23-30.
11. Wang WK, Chao DY, Kao CL, Wu HC, Lin YC, Li CM et al. High levels of plasma dengue viral load during defervescence in patients with dengue hemorrhagic fever: implications for pathogenesis. Virology 2003; 305: 330-338.
12. Halstead SB, O’Rourke EJ. Dengue viruses and mononuclear phagocytes. I. Infection enhancement by non-neutralizing antibody. J Exp Med 1977; 146: 201-217.
13. Kou Z, Quinn M, Chen H, Rodrigo WW, Rose RC, Schlesinger JJ et al. Monocytes, but not T or B cells, are the principal target cells for dengue virus (DV) infection among human peripheral blood mononuclear cells. J Med Virol 2008; 80(1): 134-146.
14. Wu SJ, Grouard-Vogel G, Sun W, Mascola JR, Brachtel E, Putvatana R et al. Human skin Langerhans cells are targets of dengue virus infection [see comments]. Nat Med 2000; 6(7): 816-820.
15. Libraty DH, Pichyangkul S, Ajariyakhajorn C, Endy TP, Ennis FA. Human dendritic cells are activated by dengue virus infection: enhancement by gamma interferon and implications for disease pathogenesis. J Virol 2001; 75(8): 3501-3508.
16. Nakao S, Lai CJ, Young NS. Dengue virus, a flavivirus, propagates in human bone marrow progenitors and hematopoietic cell lines [see comments]. Blood 1989; 74(4): 1235-1240.
17. Kurane I, Janus J, Ennis FA. Dengue virus infection of human skin fibroblasts in vitro production of IFN-beta, IL-6 and GM-CSF. Arch Virol 1992; 124: 21-30.
18. Andrews BS, Theofilopolous AN, Peters CJ, Loskutoff DJ, Brandt WE, Dixon FJ. Replication of dengue and Junin virues in cultured rabbit and human endothelial cells. Infect Immun 1978; 20: 776-781.
19. Huang YH, Lei HY, Liu HS, Lin YS, Liu CC, Yeh TM. Dengue virus infects human endothelial cells and induces IL-6 and IL-8 production. Am J Trop Med Hyg 2000; 63: 71-75.
20. Lin YL, Liu CC, Lei HY, Yeh TM, Lin YS, Chen RM et al. Infection of five human liver cell lines by dengue-2 virus. J Med Virol 2000; 60(4): 425-431.
21. Marianneau P, Cardona A, Edelman L, Deubel V, Despres P. Dengue virus replication in human hepatoma cells activates NF-kappaB which in turn induces apoptotic cell death. J Virol 1997; 71(4): 3244-3249.
22. Nishiura H, Halstead SB. Natural history of dengue virus (DEN)-1 and DEN-4 infections: reanalysis of classical studies. J Infect Dis 2007; 195: 1007-1013.
23. Taweechaisupapong S, Sriurairatana S, Angsubhakorn S, Yoksan S, Khin MM, Sahaphong S et al. Langerhans cell density and serological changes following intradermal immunisation of mice with dengue 2 virus. J Med Microbiol 1996; 45: 138-145.
24. Siler JF, Hall MW, Hitchens AP. Dengue: its history, epidemiology, mechanism of transmission, etiology, clinical manifestations, immunity, and prevention. Philippine J Sci 1926; 29: 1-304.
25. Simmons JS, St John JH, Reynolds FHK. Experimental studies of dengue. Philippine J Sci 1931; 44(1-2): 1-252.
26. Gubler DJ, Suharyono W, Lubis I, Eram S, Suliantisaroso J. Epidemic dengue hemorrhagic fever in rural Indonesia. I. Virological and epidemiological studies. Am J Trop Med Hyg 1979; 28(4): 701-710.
27. Vaughn DW, Green S, Kalayanarooj S, Innis BL, Nimmannitya S, Suntayakorn S et al. Dengue in the early febrile phase: viremia and antibody responses. J Infect Dis 1997; 176: 322-330.
28. Nimmannitya S, Halstead SB, Cohen S, Margiotta MR. Dengue and chikungunya virus infection in man in Thailand, 1962-1964. I. Observations on hospitalized patients with hemorrhagic fever. Am J Trop Med Hyg 1969; 18(6): 954-971.
29. Nisalak A, Halstead SB, Singharaj P, Udomsakdi S, Nye SW, Vinijchaikul K. Observations related to pathogenesis of dengue hemorrhagic fever. III. Virologic studies of fatal disease. Yale J Biol Med 1970; 42: 293-310.
30. Gubler DJ, Suharyono W, Tan R, Abidin M, Sie A. Viraemia in patients with naturally acquired dengue infection. Bull World Health Organ 1981; 59(4): 623-630.
31. Scott RM, Nisalak A, Cheamudon U, Seridhoranakul S, Nimmannitya S. Isolation of dengue viruses peripheral blood leukocytes of patients with hemorrhagic fever. J Infect Dis 1980; 141(1): 1-6.
32. King AD, Nisalak A, Kalayanrooj S, Myint KSA, Pattanapanyasat K, Nimmannitya S et al. B cells are the principal circulating mononuclear cells infected by dengue virus. Southeast Asian J Trop Med Public Health 1999; 30(4): 718-728.
33. Boonpucknavig S, Boonpucknavig V, Bhamarapravati N, Nimmannitya S. Immunofluorescence study of skin rash in patients with dengue hemorrhagic fever. Arch Pathol Lab Med 1979; 103: 463-466.
34. Rosen L, Drouet MT, Deubel V. Detection of dengue virus RNA by reverse transcription-polymerase chain reaction in the liver and lymphoid organs but not in the brain in fatal human infection. Am J Trop Med Hyg 1999; 61(5): 720-724.
35. Rosen L, Khin MM, U T. Recovery of virus from the liver of children with fatal dengue: reflections on the pathogenesis of the disease and its possible analogy with that of yellow fever. Res Virol 1989; 140: 351-360.
36. Huerre MR, Lan NT, Marianneau P, Hue NB, Khun H, Hung NT et al. Liver histopathology and biological correlates in five cases of fatal dengue fever in Vietnamese children. Virchows Arch 2001; 438(2): 107-115.
37. Jessie K, Fong MY, Devi S, Lam SK, Wong KT. Localization of dengue virus in naturally infected human tissues, by immunohistochemistry and in situ hybridization. J Infect Dis 2004; 189: 1411-1418.
38. Hall WC, Crowell TP, Watts DM, Barros VL, Kruger H, Pinheiro F et al. Demonstration of yellow fever and dengue antigens in formalin- fixed paraffin-embedded human liver by immunohistochemical analysis. Am J Trop Med Hyg 1991; 45(4): 408-417.
39. Innis BL, Myint KSA, Nisalak A, Ishak KG, Nimmannitya S, Laohapand T et al. Acute liver failure is one important cause of fatal dengue infection. Southeast Asian J Trop Med Public Health 1990; 21: 695-696.
40. Couvelard A, Marianneau P, Bedel C, Drouet MT, Vachon F, Henin D et al. Report of a fatal case of dengue infection with hepatitis: demonstration of dengue antigens in hepatocytes and liver apoptosis. Hum Pathol 1999; 30(9): 1106-1110.
41. Blackley S, Kou Z, Chen H, Quinn M, Rose RC, Schlesinger JJ et al. Primary human splenic macrophages, but not T or B cells, are the principal target cells for dengue virus infection in vitro. J Virol 2007; 81(24): 13325-13334.
42. Vaughn DW, Green S, Kalayanarooj S, Innis BL, Nimmannitya S, Suntayakorn S et al. Dengue viremia titer, antibody response pattern, and virus serotype correlate with disease severity. J Infect Dis 2000; 181(1): 2-9.
43. Guzman MG, Kouri G, Valdes L, Bravo J, Alvarez M, Vazquez S et al. Epidemiologic studies on dengue in Santiago de Cuba, 1997. Am J Epidemiol 2000; 152(9): 793-799.
44. Vaughn DW. Invited commentary: dengue lessons from Cuba. Am J Epidemiol 2000; 152(9): 800-803.
45. Watts DM, Porter KR, Putvatana P, Vasquez B, Calampa C, Hayes CG et al. Failure of secondary infection with American genotype dengue 2 to cause dengue haemorrhagic fever [see comments]. Lancet 1999; 354(9188): 1431-1434.
46. Leitmeyer KC, Vaughn DW, Watts DM, Salas R, Villalobos I, de Chacon et al. Dengue virus structural differences that correlate with pathogenesis. J Virol 1999; 73(6): 4738-4747.
47. Kochel TJ, Watts DM, Halstead SB, Hayes CG, Espinosa A, Felices V, Caceda R, Bautista T, Montoya Y, Douglas S, Russell KL. Effect of dengue-1 antibodies on American dengue-2 viral infection and dengue haemorrhagic fever. Lancet 2002; 360: 310-312.
48. Pryor MJ, Carr JM, Hocking H, Davidson AD, Li PX, Wright PJ. Replication of dengue virus type 2 in human monocyte-derived macrophages: comparisons of isolates and recombinant viruses with substitutions at amino acid 390 in the envelope glycoprotein. Am J Trop Med Hyg 2001; 65: 427-434.
49. Anderson JR, Rico-Hesse R. Aedes aegypti vectorial capacity is determined by the infecting genotype of dengue virus. Am J Trop Med Hyg 2006; 75: 886-892.
50. Bosch I, Xhaja K, Estevez LR, G., Melichar H, Warke RV, Fornier MV et al. Increased production of IL-8 in primary human monocytes and in human epithelial and endothelial cell lines after dengue virus challenge. J Virol 2002; 76: 5588-5597.
51. Avirutnan P, Malasit P, Seliger B, Bhakdi S, Husmann M. Dengue virus infection of human endothelial cells leads to chemokine production, complement activation, and apoptosis. J Immunol 1998; 161(11): 6338-6346.
52. Spain-Santana TA, Marglin S, Ennis FA, Rothman AL. MIP-1 alpha and MIP-1 beta induction by dengue virus. J Med Virol 2001; 65(2): 324-330.
53. King CA, Marshall JS, Alshurafa H, Anderson R. Release of vasoactive cytokines by antibody-enhanced dengue virus infection of a human mast cell/basophil line. J Virol 2000; 74(15): 7146-7150.
54. Murgue B, Roche C, Chungue E, Deparis X. Prospective study of the duration and magnitude of viraemia in children hospitalised during the 1996-1997 dengue-2 outbreak in French Polynesia. J Med Virol 2000; 60(4): 432-438.
55. Libraty DH, Endy TP, Houng HS, Green S, Kalayanarooj S, Suntayakorn S et al. Differing influences of virus burden and immune activation on disease severity in secondary dengue-3 virus infections. J Infect Dis 2002; 185(9): 1213-1221.
56. Libraty DH, Young PR, Pickering D, Endy TP, Kalayanarooj S, Green S et al. High circulating levels of the dengue virus nonstructural protein NS1 early in dengue illness correlate with the development of dengue hemorrhagic fever. J Infect Dis 2002; 186: 1165-1168.
57. Halstead SB, Shotwell H, Casals J. Studies on the pathogenesis of dengue infection in monkeys. II. Clinical laboratory responses to heterologous infection. J Infect Dis 1973; 128(1): 15-22.
58. Halstead SB. In vivo enhancement of dengue virus infection in Rhesus monkeys by passively transferred antibody. J Infect Dis 1979; 140(4): 527-533.
59. Goncalvez AP, Engle RE, St Claire M, Purcell RH, Lai CJ. Monoclonal antibody-mediated enhancement of dengue virus infection in vitro and in vivo and strategies for prevention. Proc Natl Acad Sci USA 2007; 104: 9422-9427.
60. Rosen L. The use of toxorhynchites mosquitoes to detect and propagate dengue and other arboviruses. Am J Trop Med Hyg 1981; 30(10): 177-183.
61. Marianneau P, Flamand M, Deubel V, Despres P. Apoptotic cell death in response to dengue virus infection: the pathogenesis of dengue haemorrhagic fever revisited. Clin Diagn Virol 1998; 10(2-3): 113-119.
62. Marianneau P, Steffan AM, Royer C, Drouet MT, Jaeck D, Kirn A et al. Infection of primary cultures of human Kupffer cells by dengue virus: no viral progeny synthesis, but cytokine production is evident. J Virol 1999; 73(6): 5201-5206.
63. Alcon-LePoder S, Drouet MT, Roux P, Frenkiel MP, Arborio M, Durand-Schneider AM et al. The secreted form of dengue virus nonstructural protein NS1 is endocytosed by hepatocytes and accumulates in late endosomes: implications for viral infectivity. J Virol 2005; 79(17): 11403-11411.
64. Chen HC, Lai SY, Sung JM, Lee SH, Lin YC, Wang WK et al. Lymphocyte activation and hepatic cellular infiltration in immunocompetent mice infected by dengue virus. J Med Virol 2004; 73: 419-431.
65. Boonpucknavig V, Bhamarapravati N, Boonpucknavig S, Futrakul P, Tanpaichtr S. Glomerular changes in dengue hemorrhagic fever. Arch Pathol Lab Med 1976; 100: 206-212.
66. Anderson R, Wang S, Osiowy C, Issekutz AC. Activation of endothelial cells via antibody-enhanced dengue virus infection of peripheral blood monocytes. J Virol 1997; 71(6): 4226-4232.
67. Pang T, Cardosa MJ, Guzman MG. Of cascades and perfect storms: the immunopathogenesis of dengue haemorrhagic fever-dengue shock syndrome (DHF/DSS). Immunol Cell Biol 2007; 85(1): 43-45.
68. Green S, Vaughn DW, Kalayanarooj S, Nimmannitya S, Suntayakorn S, Nisalak A et al. Early immune activation in acute dengue illness is related to development of plasma leakage and disease severity. J Infect Dis 1999; 179(4): 755-762.
69. Atrasheuskaya A, Petzelbauer P, Fredeking TM, Ignatyev G. Anti-TNF antibody treatment reduces mortality in experimental dengue virus infection. FEMS Immunol Med Microbiol 2003; 35: 33-42.
70. Fernandez-Mestre MT, Gendzekhadze K, Rivas-Vetencourt P, Layrisse Z. TNF-alpha 308A allele, a possible severity risk factor of hemorrhagic manifestatoin in dengue fever patients. Tissue Antigens 2004; 64: 468-472.
71. Kurane I, Innis BL, Nimmannitya S, Nisalak A, Meager A, Janus J et al. Activation of T lymphocytes in dengue virus infections: high levels of soluble interleukin 2 receptor, soluble CD4, soluble CD8, interleukin 2, and interferongamma in sera of children with dengue. J Clin Invest 1991; 88: 1473-1480.
72. Bethell DB, Flobbe K, Cao XT, Day NP, Pham TP, Buurman WA et al. Pathophysiologic and prognostic role of cytokines in dengue hemorrhagic fever. J Infect Dis 1998; 177(3): 778-782.
73. Green S, Pichyangkul S, Vaughn DW, Kalayanarooj S, Nimmannitya S, Nisalak A et al. Early CD69 expression on peripheral blood lymphocytes from children with dengue hemorrhagic fever. J Infect Dis 1999; 180(5): 1429-1435.
74. Gagnon SJ, Leporati A, Green S, Kalayanarooj S, Vaughn DW, Stephens HA et al. T cell receptor Vbeta gene usage in Thai children with dengue virus infection. Am J Trop Med Hyg 2001; 64(1-2): 41-48.
75. Zivny J, DeFronzo M, Jarry W, Jameson J, Cruz J, Ennis FA et al. Partial agonist effect influences the CTL response to a heterologous dengue virus serotype. J Immunol 1999; 163(5): 2754-2760.
76. Mathew A, Kurane I, Green S, Stephens HA, Vaughn DW, Kalayanarooj S et al. Predominance of HLA-restricted cytotoxic T-lymphocyte responses to serotype-cross-reactive epitopes on nonstructural proteins following natural secondary dengue virus infection. J Virol 1998; 72(5): 3999-4004.
77. Zivna I, Green S, Vaughn DW, Kalayanarooj K, Stephens HAF, Chandanayingyong D et al. T cell responses to an HLA-B*07-restricted epitope on the dengue NS3 protein correlate with disease severity. J Immunol 2002; 168: 5959-5965.
78. An J, Zhou DS, Zhang JL, Morida H, Wang JL, Yasui K. Dengue-specific CD8+ T cells have both protective and pathogenic roles in dengue virus infection. Immunol Lett 2004; 95: 167-174.
79. Gagnon SJ, Ennis FA, Rothman AL. Bystander target cell lysis and cytokine production by dengue virus- specific human CD4(+) cytotoxic T-lymphocyte clones. J Virol 1999; 73(5): 3623-3629.
80. Mongkolsapaya J, Dejnirattisai W, Xu XN. Original antigenic sin and apoptosis in the pathogenesis of dengue hemorrhagic fever. Nat Med 2003; 9: 921-927.
81. Loke H, Bethell DB, Phuong CX, Dung M, Schneider J, White NJ et al. Strong HLA class I-restricted T cell responses in dengue hemorrhagic fever: a double-edged sword? J Infect Dis 2001; 184(11): 1369-1373.
82. Stephens HA, Klaythong R, Sirikong M, Vaughn DW, Green S, Kalayanarooj K et al. HLA-A and -B allele associations with secondary dengue virus infections correlate with disease severity and infecting viral serotype in ethnic Thais. Tissue Antigens 2002; 60: 309-318.
83. Loke H, Bethell D, Phuong CX, Day NP, White NJ, Farrar J et al. Susceptibility to dengue hemorrhagic fever in Vietnam: evidence of an association with variation in the vitamin D receptor and Fc gamma receptor IIa genes. Am J Trop Med Hyg 2002; 67: 102-106.
84. Sakuntabhai A, Turbpaiboon C, Casademont I, Chuansumrit A, Lowhnoo T, Kajaste-Rudnitski A et al. A variant in the CD209 promoter is associated with severity of dengue disease. Nat Genet 2005; 37(5): 507-513.
85. Bokisch VA, Top FH Jr, Russell PK, Dixon FJ, Muller-Eberhard HJ. The potential pathogenic role of complement in dengue hemorrhagic shock syndrome. N Engl J Med 1973; 289: 996-1000.
86. Halstead SB. Antibody, macrophages, dengue virus infection, shock, and hemorrhage: a pathogenetic cascade. Rev Infect Dis 1989; 11(Suppl 4): S830-S839.
87. Halstead SB. Pathogenesis of dengue: challenges to molecular biology. Science 1988; 239: 476-481.
88. Sobel AT, Bokisch VA, Muller-Eberhard HJ. C1q deviation tests for the detection of immune complexes, aggregates of IgG, and bacterial products in human serum. J Exp Med 1975; 142: 139-150.
89. Theofilopoulos AN, Wilson CB, Dixon FJ. The Raji cell radioimmune assay for detecting immune complexes in human sera. J Clin Investig 1976; 67: 169-182.
90. Ruangjirachuporn W, Boonpucknavig S, Nimmannitya S. Circulating immune complexes in serum from patients with dengue haemorrhagic fever. Clin Exp Immunol 1979; 36: 46-53.
91. Malasit P. Complement and dengue haemorrhagic fever/shock syndrome. Southeast Asian J Trop Med Public Health 1987; 18(3): 316-320.
92. Warke RV, Xhaja K, Martin KJ, Fournier MF, Shaw SK, Brizuela N et al. Dengue virus induces novel changes in gene expression of human umbilical vein endothelial cells. J Virol 2003; 77: 11822-11832.
93. Young PR, Hilditch PA, Bletchly C, Halloran W. An antigen capture enzyme-linked immunosorbent assay reveals high levels of the dengue virus protein NS1 in the sera of infected patients. J Clin Microbiol 2000; 38(3): 1053-1057.
94. Alcon S, Talarmin A, Debruyne M, Falconar A, Deubel V, Flamand M. Enzyme-linked immunosorbent assay reveals high levels of the dengue virus protein NS1 in the sera of infected patients. J Clin Microbiol 2002; 40: 376-381.
95. Mathew A, Kurane I, Green S, Vaughn DW, Kalayanarooj S, Suntayakorn S et al. Impaired T cell proliferation in acute dengue infection. J Immunol 1999; 162(9): 5607-5615.
96. Rouse BT, Horohov DW. Immunosuppression in viral infections. Rev Infect Dis 1986; 8: 850-873.
97. Hirsch RL, Griffen DE, Johnson RT. Cellular immune responses during complicated and uncomplicated measles virus infections of man. Clin Immunol Immunopathol 1984; 31: 1-12.
98. Carney WP, Hirsch MS. Mechanisms of immunosuppression in cytomegalovirus mononucleosis. II. Virus-monocyte interactions. J Infect Dis 1981; 144: 47-54.
99. Borrow P, Oldstone MBA. Measles virus-mononuclear cell interactions. Curr Top Microbiol Immunol 1995; 191: 85-100.
100. Welsh RM, McNally JM. Immune deficiency, immune silencing and clonal exhaustion of T cell reponses during viral infections. Curr Opin Microbiol 1999; 2: 382-387.
101. Myint KSA, Mongkolsirichaikul D, Manomuth C, Kalayanarooj S, Vaughn DW, Nisalak A et al. Apoptosis of peripheral blood mononuclear cells (PBMCS) in children with acute dengue. In: Annual Meeting of the American Society of Tropical Medicine and Hygiene, 28 November-2 December 1999, Washington, D.C, p. 211.
102. Despres P, Flamand M, Ceccaldi PE, Deubel V. Human isolates of dengue type 1 virus induce apoptosis in mouse neuroblastoma cells. J Virol 1996; 70: 4090-4096.
103. Despres P, Frenkiel MP, Ceccaldi PE, Duarte Dos Santos C, Deubel V. Apoptosis in the mouse central nervous system in response to infection with mouse-neurovirulent dengue viruses. J Virol 1998; 72(1): 823-829.
104. Marianneau P, Flamand M, Courageot MP, Deubel V, Despres P. [Apoptotic cell death in response to dengue virus infection: what are the consequences of viral pathogenesis?]. Ann Biol Clin (Paris) 1998; 56(4): 395-405.
105. Marianneau P, Flamand M, Deubel V, Despres P. Apoptotic cell death in response to dengue virus infection: the pathogenesis of dengue haemorrhagic fever revisited [In Process Citation]. Clin Diagn Virol 1998; 10(2-3): 113-119.
106. Thongtan T, Panyim S, Smith DR. Apoptosis in dengue virus infected liver cell lines HepG2 and Hep3B. J Med Virol 2004; 72(3): 436-444.
107. Wills BA, Oragui EE, Dung NM, Loan HT, Chau NV, Farrar JJ et al. Size and charge characteristics of the protein leak in dengue shock syndrome. J Infect Dis 2004; 190: 810-818.
108. Bethell DB, Gamble J, Pham PL, Nguyen MD, Tran TH, Ha TH et al. Noninvasive measurement of microvascular leakage in patients with dengue hemorrhagic fever. Clin Infect Dis 2001; 32(2): 243-253.
109. Kalayanarooj S, Vaughn DW, Nimmannitya S, Green S, Suntayakorn S, Kunentrasai N et al. Early clinical and laboratory indicators of acute dengue illness. J Infect Dis 1997; 176(2): 313-321.
110. Green S, Vaughn DW, Kalayanarooj S, Nimmannitya S, Suntayakorn S, Nisalak A et al. Elevated plasma interleukin-10 levels in acute dengue correlate with disease severity. J Med Virol 1999; 59(3): 329-334.
111. Pries AR, Kuebler WM. Normal endothelium. Handb Exp Pharmacol 2006; 176(Pt 1): 1-40.
112. Cardier JE, Rivas B, Romano E, Rothman AL, Perez-Perez C, Ochoa M et al. Evidence of vascular damage in dengue disease: demonstration of high levels of soluble cell adhesion molecules and circulating endothelial cells. Endothelium 2006; 13(5): 335-340.
113. Rehm M, Zahler S, Lotsch M, Welsch U, Conzen P, Jacob M et al. Endothelial glycocalyx as an additional barrier determining extravasation of 6% hydroyethyl starch or 5% albumin solutions in the coronary vascular bed. Anesthesiology 2004; 100: 1211-1223.
114. Sahaphong S, Riengrojpitak S, Bhamarapravati N, Chirachariyavej T. Electron microscopic study of the vascular endothelial cell in dengue hemorrhagic fever. Southeast Asian J Trop Med Public Health 1980; 11: 194-204.
115. Jacobs M, Levin M. An improved endothelial barrier model to investigate dengue hemorrhagic fever. J Virol Methods 2002; 104: 173-185.
116. Carr JM, Hocking H, Bunting K, Wright PJ, Davidson AD, Gamble J et al. Supernatants from dengue virus type-2 infected macrophages induce permeability changes in endothelial cell monolayers. J Med Virol 2003; 69: 521-528.
117. Burke-Gaffney A, Keenan AK. Modulation of human endothelial cell permeability by combinations of the cytokines interleukin-1, tumor necrosis factor-alpha and interferon-gamma. Immunopharmacology 1993; 25: 1-9.
118. Rosenstein N, Ettinghausen SE, Rosenberg SA. Extravasation of intravascular fluid mediated by the systemic administration of recombinant interleukin 2. J Immunol 1986; 137: 1735-1742.
119. Maruo N, Morita I, Shirao M, Murota S. IL-6 increased endothelial permeability in vitro. Endocrinology 1992; 131: 710-714.
120. Talavera D, Castillo AM, Cominguez MC, Gutierrez AE, Meza I. IL8 release, tight junction and cytoskeleton dynamic reorganization conducive to permeability increase are induced by dengue virus infection of microvascular endothelial monolayers. J Gen Virol 2004; 85: 1801-1813.
121. Beynon HL, Haskard DO, Davies KA, Haroutunian R, Walport MJ. Combinations of low concentrations of cytokines and acute agonists synergize in increasing the permeability of endothelial monolayers. Clin Exp Immunol 1993; 91: 314-319.
122. Sirois MG, de Lima WT, de Brum Fernandes AI, Johnson RJ, Plante GE, Sirois P. Effect of PAF on rat lung vascular permeability, role of platelets and polymorphonuclear leucocytes. Br J Pharmacol 1994; 111: 1111-1116.
123. Murohara K, Horowitz JR, Silver M, Tsurumi Y, Chen D, Sullivan A et al. Vascular endothelial growth factor/vascular permeability factor enhances vascular permeability via nitric oxide and prostcyclin. Circulation 1998; 97: 99-107.
124. Rollin S, Lernieux C, Maliba R, Favier J, Villeneuve LR, Allen BG et al. VEGF-mediated endothelial P-selection translocation role of BEGF receptors and endogenous PAF synthesis. Blood 2004; 103: 3789-3797.
125. Hober D, Nguyen TL, Shen L, Ha DQ, Huong VT, Benyoucef S et al. Tumor necrosis factor alpha levels in plasma and whole-blood culture in dengue-infected patients: relationship between virus detection and preexisting specific antibodies. J Med Virol 1998; 54(3): 210-218.
126. Juffrie M, van Der Meer GM, Hack CE. Inflammatory mediators in dengue virus infection in children: interleukin-8 and its relationship to neutraophil degranulation. Infect Immun 2000; 68: 702-707.
127. Chaturvedi UC, Elbishbishi EA, Agarwal R, Raghupathy R, Nagar R, Tandon R et al. Sequential production of cytokines by dengue virusinfected human peripheral blood leukocyte cultures. J Med Virol 1999; 59(3): 335-340.
128. Tuchinda M, Dhorranintra B, Tuchinda P. Histamine content in 24-hour urine in patients with dengue haemorrhagic fever. Southeast Asian J Trop Med Public Health 1977; 8(1): 80-83.
129. Phan DT, Ha NT, Thuc LT, Diet NH, Phu LV, Ninh LY et al. Some changes in immunity and blood in relation to clinical states of dengue hemorrhagic fever patients in Vietnam. Haematologia (Budap) 1991; 24: 13-21.
130. Yang KD, Wang CL, Shaio MF. Production of cytokines and platelet activating factor in secondary dengue virus infections. J Infect Dis 1995; 172: 604-605.
131. Tseng CS, Lo HW, Teng HC, Lo WC, Ker CG. Elevated levels of plasma VEGF in patients with dengue hemorrhagic fever. FEMS Immunol Med Microbiol 2005; 43(1): 99-102.
132. Mitrakul C, Poshyachinda M, Futrakul P, Sangkawibha N, Ahandrik S. Hemostatic and platelet kinetic studies in dengue hemorrhagic fever. Am J Trop Med Hyg 1977; 26(5): 975-984.
133. Mitrakul C. Bleeding problem in dengue haemorrhagic fever: platelets and coagulation changes. Southeast Asian J Trop Med Public Health 1987; 18: 407-412.
134. Nelson ER, Bierman HR, Chulajata R. Hematologic findings in the 1960 hemorrhagic fever epidemic (dengue) in Thailand. Am J Trop Med Hyg 1964; 13: 642-649.
135. Bierman HR, Nelson ER. Hematodepressive virus diseases of Thailand. Ann Intern Med 1965; 62(5): 867-883.
136. Bhamarapravati N, Tuchinda P, Boonyapaknavik V. Pathology of Thailand haemorrhagic fever: a study of 100 autopsy cases. Ann Trop Med Parasitol 1967; 61: 500-510.
137. La Russa VF, Innis BL. Mechanisms of dengue virus-induced bone marrow suppression. Baillieres Clin Haematol 1995; 8: 249-270.
138. Murgue B, Cassar O, Deparis X, Guigon M, Chungue E. Implication of macrophage inflammatory protein-1alpha in the inhibition of human haematopoietic progenitor growth by dengue virus. J Gen Virol 1998; 79(Pt 8): 1889-1893.
139. Binder D, Fehr J, Hengartner H, Zinkernagel RM. Virus-induced transient bone marrow aplasia: major role of interferon-alpha/beta during acute infection with the noncytopathic lymphocyteic choriomeningitis virus. J Exp Med 1997; 185: 517-530.
140. Kurane I, Innis BL, Nimmannitya S, Nisalak A, Meager A, Ennis FA. High levels of interferon-alpha in the sera of children with dengue virus infection. Am J Trop Med Hyg 1993; 48: 222-229.
141. Wang S, He RT, Patarapotikul J, Innis BL, Anderson R. Antibody-enhanced binding of dengue-2 virus to human platelets. Virology 1995; 213: 254-257.
142. Lin CF, Lei HY, Liu CC, Liu HS, Yeh TM, Wang ST et al. Generation of IgM anti-platelet autoantibody in dengue patients. J Med Virol 2001; 63(2): 143-149.
143. Lum CS, Goh YT, Chan WK, EL-Amin A-L, Lam SK. Risk factors for hemorrhage in severe dengue infections. J Pediatr 2002; 140: 629-631.
144. Krishnamurti C, Kalayanarooj S, Cutting MA, Peat RA, Rothwell SW, Reid TJ et al. Mechanisms of hemorrhage in dengue without circulatory collapse. Am J Trop Med Hyg 2001; 65(6): 840-847.
145. Wills BA, Oragui EE, Stephens AC, Daramola OA, Dung NM, Loan HT et al. Coagulation abnormalities in dengue hemorrhagic fever: serial investigations in 167 Vietnames children with dengue shock syndrome. Clin Infect Dis 2002; 35: 277-285.
146. Pongpanich B. Hemodynamic changes in shock associated with dengue haemorrhagic fever. Southeast Asian J Trop Med Public Health 1987; 18: 326-330.
147. Pongpanich B, Kumponpant S. Studies of dengue hemorrhagic fever. V. Hemodynamic studies of clinical shock associated with dengue hemorrhagic fever. J Pediatr 1973; 83: 1073-1077.
148. Mangada MM, Rothman AL. Altered cytokine responses of dengue-specific CD4+ T cells to heterologous serotypes. J Immunol 2005; 175: 2676-2683.
149. Rothman AL, Ennis FA. Immunopathogenesis of dengue hemorrhagic fever. Virology 1999; 257(1): 1-6.
150. Rothman AL. Immunology and immunopathogenesis of dengue disease. Adv Virus Res 2003; 60: 397-419.
151. Rothman A. Dengue: defining protective versus pathologic immunity. J Clin Investig 2004; 113: 946-951.
152. Green S, Rothman A. Immunopathological mechanisms in dengue and dengue hemorrhagic fever. Curr Opin Infect Dis 2006; 19: 429-436.
153. Fink J, Gu F, Vasudevan SG. Role of T cells, cytokines and antibody in dengue fever and dengue haemorrhagic fever. Rev Med Virol 2006; 16: 263-275.
154. Halstead SB, O’Rourke EJ. Antibody-enhanced dengue virus infection in primate leukocytes. Nature 1977; 265(5596): 739-741.
155. Halstead SB. The Alexander D. Langmuir Lecture: the pathogenesis of dengue - molecular epidemiology in infectious disease. Am J Epidemiol 1981; 114(5): 632-648.
156. Mahalingam S, Lidbury BA. Suppression of lipopolysaccharide-induced antiviral transcription factor (STAT-1 and NF-kB) complexes by antibodydependent enhancement of macrophage infection by Ross River virus. Proc Natl Acad Sci USA 2002; 99: 13819-13824.
157. Chareonsirisuthigul T, Kalayanarooj S, Ubol S. Dengue virus (DENV) antibody-dependent enhancement of infection upregulates the production of anti-inflammatory cytokines, but suppresses anti-DENV free radical and pro-inflammatory cytokine production, in THP-1 cells. J Gen Virol 2007; 88(Pt 2): 365-375.
158. Boonnak K, Slike BM, Burgess TH, Mason RM, Wu SJ, Sun P et al. Role of dendritic cells in antibody-dependent enhancement of dengue virus infection. J Virol 2008; 82(8): 3939-3951.
159. Simmons CP, Popper S, Dolocek C, Chau TN, Griffiths M, Dung NT et al. Patterns of host genome-wide gene transcript abundance in the peripheral blood of patients with acute dengue hemorrhagic fever. J Infect Dis 2007; 195(8): 1097-1107.
160. Ubol S, Masrinoul P, Jaijarnwanich J, Kalayanarooj SM, Chareonsirisuthikul T, Kasisith J. Differences in PBMC-global gene expression indicate a significant role in the innate responses in DF but not DHF progression. J Infect Dis 2008; 197(10): 1459-1467.
161. Azeredo EL, Zagne SM, Santiago MA, Gouvea AS, Santana AA, Neves-Souza PC et al. Characterisation of lymphocyte response and cytokine patterns in patients with dengue fever. Immunobiology 2001; 204: 494-507.
162. Raghupathy R, Chaturvedi UC, Al-Sayer H, Elbishbishi EA, Agarwal R, Nagar R et al. Elevated levels of IL-8 in dengue hemorrhagic fever. J Med Virol 1998; 56(3): 280-285.
163. Pasca WS, Agarwal R, Elbishbishi EA, Chaturvedi UC, Nagar R, Mustafa AS. Role of interleukin-12 in patients with dengue hemorrhagic fever. FEMS Immunol Med Microbiol 2000; 28: 151-155.
164. Srikiatkhachorn A, Ajanyakhajorn C, Endy TP. Virus indived decline in soluble endothelial growth receptor 2 is associated with plasma leakage in dengue hemorrhagic fever. J Virol 2007; 81: 1592-1600.
165. Chen LC, Lei HY, Liu CC, Shiesh SC, Chen SH, Liu HS et al. Correlation of serum levels of macrophage migration inhibitory factor with disease severity and clinical outcome in dengue patients. Am J Trop Med Hyg 2006; 74(1): 142-147.
166. Avirutnan P, Punyadee N, Noisakran S, Komoltri C, Thiemmeca S, Auethavornanan K et al. Vascular leakage in severe dengue virus infections: a potential role for the nonstructural viral protein NS1 and complement. J Infect Dis 2006; 193: 1078-1088.
167. Hober D, Poli L, Roblin B, Gestas P, Chungue E, Granic G et al. Serum levels of tumor necrosis factor-alpha (TNF-alpha), interleukin-6 (IL-6), and interleukin-1-beta (IL-1-beta) in dengue-infected patients. Am J Trop Med Hyg 1993; 48: 324-331.
168. Kuno G, Bailey RE. Cytokine responses to dengue infection among Puerto Rican patients. Mem Inst Oswaldo Cruz (Rio de Janeiro) 1994; 89: 179-182.
169. Mustafa AS, Elbishbishi EA, Agarwal R, Chaturvedi UC. Elevated levels of interleukin-13 and IL-18 in patients with dengue hemorrhagic fever. FEMS Immunol Med Microbiol 2001; 30(3): 229-233.
170. Lin YL, Liu CC, Chuang JL, Lei HY, Yeh TM, Lin YS et al. Involvement of oxidative stress, NF-IL-6 and RANTES expression in dengue-2-virusinfected human liver cells. Virology 2000; 276: 114-126.
171. Gagnon SJ, Mori M, Kurane I, Green S, Vaughn DW, Kalayanarooj S et al. Cytokine gene expression and protein production in peripheral blood mononuclear cells of children with acute dengue virus infections. J Med Virol 2002; 67: 41-46.